Sale!

MT-TL2 Gene Encephalomyopathy mitochondrial MT-TL2 related Genetic Test

4,400 د.إ

-21%

The MT-TL2 gene encodes for mitochondrial tRNA for leucine (UUA/G), and mutations in this gene can lead to mitochondrial encephalomyopathy, a condition characterized by brain and muscle dysfunction due to issues in mitochondrial energy production. The MT-TL2-related genetic test is a specialized diagnostic tool designed to identify mutations in the MT-TL2 gene, which can help in diagnosing mitochondrial encephalomyopathy linked to this gene. This test is crucial for confirming the diagnosis, understanding the disease progression, and informing treatment strategies for affected individuals.

The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the MT-TL2 gene encephalomyopathy-related genetic test is 4400 AED. Conducted in a state-of-the-art laboratory by experienced professionals, this test offers a reliable diagnosis for patients suspected of having mitochondrial disorders associated with the MT-TL2 gene. Early detection through this test can be instrumental in managing symptoms and improving the quality of life for those affected by mitochondrial encephalomyopathy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MT-TL2 Gene Encephalomyopathy Mitochondrial MT-TL2 Related Genetic Test

Welcome to DNA Labs UAE, where we offer the MT-TL2 gene encephalomyopathy mitochondrial MT-TL2 related genetic test. This diagnostic test is used to detect mutations in the MT-TL2 gene that are associated with mitochondrial encephalomyopathy.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the MT-TL2 gene encephalomyopathy mitochondrial MT-TL2 related NGS genetic DNA test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with MT-TL2 gene encephalomyopathy mitochondrial MT-TL2 related.

Test Details

The MT-TL2 gene encephalomyopathy mitochondrial MT-TL2 related NGS genetic test is a diagnostic test that uses next-generation sequencing (NGS) technology to sequence the entire MT-TL2 gene. This allows for the identification of any mutations or variations that may be present. Mitochondrial encephalomyopathy is a rare genetic disorder that affects the function of mitochondria, the energy-producing organelles within cells. Symptoms of this disorder can include muscle weakness, seizures, developmental delays, and cognitive impairment. Mutations in the MT-TL2 gene have been linked to mitochondrial encephalomyopathy.

Genetic testing plays a crucial role in diagnosing mitochondrial encephalomyopathy and guiding treatment decisions. NGS genetic testing is a powerful tool for detecting mutations in the MT-TL2 gene and other genes associated with mitochondrial disorders. This technology allows for the rapid and accurate sequencing of large stretches of DNA, making it possible to identify even rare mutations that may be missed by other diagnostic tests. NGS testing is often used in conjunction with other diagnostic tools, such as clinical evaluations and biochemical tests, to provide a comprehensive diagnosis of mitochondrial encephalomyopathy and other mitochondrial disorders.

Test Name MT-TL2 Gene Encephalomyopathy mitochondrial MT-TL2 related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MT-TL2 Gene Encephalomyopathy, mitochondrial, MT-TL2 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MT-TL2 Gene Encephalomyopathy, mitochondrial, MT-TL2 related
Test Details

MT-TL2 gene encephalomyopathy, mitochondrial, MT-TL2 related NGS genetic test is a diagnostic test used to detect mutations in the MT-TL2 gene that are associated with mitochondrial encephalomyopathy. This test uses next-generation sequencing (NGS) technology to sequence the entire MT-TL2 gene and identify any mutations or variations that may be present.

Mitochondrial encephalomyopathy is a rare genetic disorder that affects the function of mitochondria, the energy-producing organelles within cells. Symptoms of this disorder can include muscle weakness, seizures, developmental delays, and cognitive impairment. Mutations in the MT-TL2 gene have been linked to mitochondrial encephalomyopathy, and genetic testing can help diagnose this disorder and guide treatment decisions.

NGS genetic testing is a powerful tool for detecting mutations in the MT-TL2 gene and other genes associated with mitochondrial disorders. This technology allows for the rapid and accurate sequencing of large stretches of DNA, making it possible to identify even rare mutations that may be missed by other diagnostic tests. NGS testing is often used in conjunction with other diagnostic tools, such as clinical evaluations and biochemical tests, to provide a comprehensive diagnosis of mitochondrial encephalomyopathy and other mitochondrial disorders.